|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,495.00 TWD | +3.46% |
|
+17.72% | +218.09% |
| 18/06 | PharmaEssentia Rebuffs Media Report Speculating Profit, Revenue for 2026 | MT |
| 11/06 | PharmaEssentia Completes Enrollment for Phase III Primary Myelofibrosis Drug Study | MT |
| Market Cap | 56TCr 1.73TCr 1.51TCr 1.39TCr 1.29TCr 2.45TCr 1,64100Cr 2.49TCr 17TCr 6.5TCr 81TCr 6.49TCr 6.35TCr 2,79900Cr | P/E 2026 * |
51.8x | P/E 2027 * | 37.7x |
|---|---|---|---|---|---|
| Enterprise Value | 53TCr 1.65TCr 1.44TCr 1.33TCr 1.23TCr 2.34TCr 1,56200Cr 2.37TCr 16TCr 6.19TCr 77TCr 6.18TCr 6.05TCr 2,66500Cr | EV / Sales 2026 * |
21.1x | EV / Sales 2027 * | 15.1x |
| Free-Float |
78.15% | Yield 2026 * |
0.05% | Yield 2027 * | 0.08% |
| 1 day | +3.46% | ||
| 1 week | +17.72% | ||
| Current month | +11.57% | ||
| 1 month | +59.55% | ||
| 3 months | +136.55% | ||
| 6 months | +199.00% | ||
| Current year | +218.09% |
| 1 week | 1,320 |  | 1,540 |
| 1 month | 907 | | 1,540 |
| Current year | 470 | | 1,540 |
| 1 year | 438.85 | | 1,540 |
| 3 years | 246.91 | | 1,540 |
| 5 years | 62.18 | | 1,540 |
| 10 years | 48.3 | | 1,540 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 01/01/2003 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 14/10/2015 |
Albert Qin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ching Liu Chan
CHM | Chairman | - | 01/09/2003 |
Cheng Ku Huang
BRD | Director/Board Member | - | - |
Chao Ho Chen
BRD | Director/Board Member | - | 30/06/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.46% | +17.72% | +206.66% | +364.07% | 1.68TCr | |
| -0.10% | +0.10% | +74.33% | +133.26% | 5.77TCr | |
| -3.80% | -6.24% | +67.04% | +86.36% | 5.47TCr | |
| +0.17% | +1.36% | -14.29% | -11.73% | 2.38TCr | |
| +1.12% | +5.68% | +16.22% | +467.37% | 2.42TCr | |
| -2.70% | +4.25% | +40.38% | -3.72% | 1.98TCr | |
| +3.78% | +5.65% | +44.99% | -26.23% | 1.71TCr | |
| -1.81% | +18.00% | +41.99% | - | 1.56TCr | |
| +2.18% | +4.43% | +28.67% | +194.25% | 1.4TCr | |
| +3.47% | +2.24% | +89.85% | +150.53% | 1.22TCr | |
| Average | +0.58% | +5.04% | +59.58% | +150.46% | 2.56TCr | |
| Weighted average by Cap. | -0.27% | +3.20% | +59.40% | +139.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.51TCr 78Cr 68Cr 63Cr 58Cr 110.66Cr 7.4TCr 112.45Cr 754.16Cr 293.28Cr 3.65TCr 292.78Cr 286.44Cr 13TCr | 3.46TCr 107.55Cr 94Cr 87Cr 80Cr 152.62Cr 10TCr 155.08Cr 1.04TCr 404.48Cr 5.04TCr 403.79Cr 395.05Cr 17TCr |
| Net income | 1.08TCr 34Cr 30Cr 27Cr 25Cr 48Cr 3.2TCr 49Cr 326.13Cr 126.83Cr 1.58TCr 126.61Cr 123.87Cr 5.46TCr | 1.5TCr 47Cr 41Cr 38Cr 35Cr 66Cr 4.42TCr 67Cr 450.01Cr 175Cr 2.18TCr 174.7Cr 170.92Cr 7.53TCr |
| Net Debt | -2.65TCr -83Cr -72Cr -67Cr -62Cr -117.11Cr -7.83TCr -119Cr -798.12Cr -310.38Cr -3.87TCr -309.85Cr -303.14Cr -13TCr | -3.47TCr -108.06Cr -95Cr -87Cr -81Cr -153.34Cr -10TCr -155.81Cr -1.04TCr -406.37Cr -5.06TCr -405.68Cr -396.9Cr -17TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/26/07 | NT$1,495.00 | +3.46% | 35,54,280 |
| 06/26/06 | NT$1,445.00 | +3.58% | 26,23,208 |
| 03/26/03 | NT$1,395.00 | 0.00% | 32,05,716 |
| 02/26/02 | NT$1,395.00 | +2.57% | 26,00,601 |
| 01/26/01 | NT$1,360.00 | +1.49% | 26,75,199 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
